Erratum: Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: a Non-Randomized, Retrospective Observational Registration: Erratum.

[This corrects the article DOI: 10.1159/000499246.].

In the article entitled “Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: A Non-Randomized, Retrospective Observational Registration” published in Current Urology 2020;14(3):142–149 (DOI: 10.1159/000499246), the following Statement of Ethics was omitted: “The study (GZA study nr. 170701RETRO) was approved by the Ethics Committee of the Sint-Augustinus Hospital Wilrijk – Antwerp (Belgium) on July, 11th, 2017. The study was conducted in compliance with the principles of the Declaration of Helsinki (2013), the principles of Good Clinical Practice, and in accordance with all applicable regulatory requirements. For this type of study formal consent is not required.” We apologize for this error and any inconvenience this may have caused.